EQS-Adhoc: Semperit AG Holding: Executive Board proposes basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 2.00 to EUR 3.50 per share for 2022

EQS-Ad-hoc: Semperit AG Holding / Key word(s): Dividend
Semperit AG Holding: Executive Board proposes basic dividend of EUR 1.50 per
share plus a conditional additional dividend of EUR 2.00 to EUR 3.50 per share
for 2022

01-March-2023 / 17:31 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation
(EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

══════════════════════════════════════════════════════════════════════════════

Ad-hoc information

Semperit Executive Board proposes basic dividend of EUR 1.50 per share plus a
conditional additional dividend of EUR 2.00 to EUR 3.50 per share for 2022

Vienna, Austria, 1 March 2023 – The Executive Board of Semperit AG Holding has
decided to propose to the Annual General Meeting a basic dividend of EUR 1.50
per share as well as a conditional additional dividend of EUR 2.00 to EUR 3.50
per share for the 2022 financial year. This results in a total dividend
proposal of a maximum of EUR 5.00 per share for the 2022 financial year
(previous year: EUR 1.50 per share). The basic dividend will be paid out on
3 May 2023.

The entitlement to the additional dividend depends on the sale of the medical
business (Sempermed; production of examination gloves including sales
organisation first) by 30 September 2023. The closing of the sale of the
medical business is, in particular, still subject to the approval of the
foreign direct investment control and competition authorities.

The exact amount of the additional dividend proposal depends on the economic
outlook and on organic and inorganic growth projects becoming more
substantiated. The Executive Board will announce a more concrete additional
dividend proposal in due time before the Annual General Meeting of Semperit AG
Holding on 25 April 2023.

This one-time deviation from the dividend policy of Semperit AG Holding should
be seen in light of the successful separation from the medical business.

 

For questions, please contact:
 

Alexander Kleedorfer    Judit Helenyi
 
Director Group Brand Management Director Investor Relations
(interim),  
Corporate Spokesperson   
+43 676 8715 8310
+43 676 8715 8464 [2]judit.helenyi@semperitgroup.com
[1]alexander.kleedorfer@semperitgroup.com  

 

[3] www.semperitgroup.com

[4] www.linkedin.com/company/semperit-ag

 

══════════════════════════════════════════════════════════════════════════════

01-March-2023 CET/CEST News transmitted by EQS Group AG. www.eqs.com

══════════════════════════════════════════════════════════════════════════════

Language: English
Company: Semperit AG Holding
Am Belvedere 10
1100 Wien
Austria
Phone: +43 1 79 777-310
Fax: +43 1 79 777-602
E-mail: judit.helenyi@semperitgroup.com
Internet: www.semperitgroup.com
ISIN: AT0000785555
Listed: Vienna Stock Exchange (Official Market)
EQS News ID: 1572419

 
End of Announcement EQS News Service

1572419  01-March-2023 CET/CEST

References

Visible links
1. monika.riedel@semperitgroup.com
2. judit.helenyi@semperitgroup.com
3. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=a1853d2543b65a06a0c38b7d8493c4a0&application_id=1572419&site_id=apa_ots_austria&application_name=news
4. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=1d0be88a25595ba48a3754775b0ada37&application_id=1572419&site_id=apa_ots_austria&application_name=news

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS. www.ots.at
© Copyright APA-OTS Originaltext-Service GmbH und der jeweilige Aussender